Momentum Biotechnologies Expands Capabilities Through OmicScouts GmbH Acquisition

Momentum Biotechnologies acquires OmicScouts GmbH, gaining access to proteomic assays and expanding into the European market.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here